🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07741591
Starting soon Observational

Impact of Perioperative Antibiotic Use on Surgical Scarring

NCT07741591 · tracked via the Priya Life Science China tracker
Sponsor
Nanfang Hospital, Southern Medical University
Phase
Observational
Started
2026-08-03
Last updated
2026-08-03

Condition(s) studied

Surgical ScarPostoperative Scar

Investigational drug(s) / intervention(s)

Perioperative Antibiotic Exposure

Perioperative Antibiotic Exposure: Patterns of perioperative antibiotic use documented in existing medical records, including timing, indication, antibiotic type, duration, frequency, and route of administration. No antibiotic treatment will be assigned or provided by the study.

Study summary

This retrospective observational cohort study will evaluate whether perioperative antibiotic use is associated with long-term surgical scar outcomes. The study will include adult patients who underwent body surface surgery at Nanfang Hospital between January 1, 2005 and January 1, 2025 and have available surgical, medication, and scar-related clinical records.

The study will not assign participants to any treatment. Researchers will review existing medical records, perioperative antibiotic exposure, surgical characteristics, complications, and scar assessments or photographs. Scar outcomes will be assessed using modified visual analogue scale scores, scar width, scar type, and scar-related complications.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older. * Underwent body surface surgery at Nanfang Hospital between January 1, 2005 and January 1, 2025, with a linear surgical incision scar. * Presented to the Department of Plastic Surgery at Nanfang Hospital for surgical scar-related care. * Had no medical encounter record at Nanfang Hospital from January 1, 2025 to the time of study screening. * Available clear surgical records and perioperative medication records. Exclusion Criteria: * Known tendency for pathological scarring or scar constitution. * History of chronic skin disease in the surgical area, such as psoriasis or eczema. * Uncontrolled diabetes mellitus, malnutrition, hypoalbuminemia, or long-term use of immunosuppressive agents or glucocorticoids. * Target scar received any scar-specific treatment after surgery, such as laser therapy, radiotherapy, drug injection, or surgical revision.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Nanfang Hospital, Southern Medical University Guangzhou Guangdong

More Nanfang Hospital, Southern Medical University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07741591 on ClinicalTrials.gov ↗ ← All trials in China